Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialysis Patients Transcript
Source: SeekingAlpha
2026-04-28 17:21:40 ET
Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialysis Patients April 28, 2026 8:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Humacyte, Inc. (HUMA) Discusses Unmet Needs and Advances in Dialysis Access with ATEV for Hemodialysis Patients Transcript
Humacyte Inc. Warrant
NASDAQ: HUMAW
HUMAW Trading
-12.93% G/L:
$0.0505 Last:
960 Volume:
$0.0445 Open:
HUMAW Latest News
HUMAW Stock Data
$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
